Development and evaluation of an ethical guideline for decisions to limit life-prolonging treatment in advanced cancer: protocol for a monocentric mixed-method interventional study

Background: Many patients with advanced cancer receive chemotherapy close to death and are referred too late to palliative or hospice care, and therefore die under therapy or in intensive care units. Oncologists still have difficulties in involving patients appropriately in decisions about limiting...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Laryionava, Katsiaryna (VerfasserIn) , Mehlis, Katja (VerfasserIn) , Winkler, Eva C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15.06.18
In: JMIR Research Protocols
Year: 2018, Jahrgang: 7, Heft: 6
ISSN:1929-0748
DOI:10.2196/resprot.9698
Online-Zugang:Verlag, Volltext: https://doi.org/10.2196/resprot.9698
Verlag: https://www.researchprotocols.org/2018/6/e157/
Volltext
Verfasserangaben:Katsiaryna Laryionava, Katja Mehlis, Elena Bierwirth, Friederike Mumm, Wolfgang Hiddemann, Pia Heußner, Eva C. Winkler

MARC

LEADER 00000caa a2200000 c 4500
001 1690896442
003 DE-627
005 20220818000118.0
007 cr uuu---uuuuu
008 200225s2018 xx |||||o 00| ||eng c
024 7 |a 10.2196/resprot.9698  |2 doi 
035 |a (DE-627)1690896442 
035 |a (DE-599)KXP1690896442 
035 |a (OCoLC)1341308022 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Laryionava, Katsiaryna  |e VerfasserIn  |0 (DE-588)1038265509  |0 (DE-627)756900255  |0 (DE-576)392240955  |4 aut 
245 1 0 |a Development and evaluation of an ethical guideline for decisions to limit life-prolonging treatment in advanced cancer  |b protocol for a monocentric mixed-method interventional study  |c Katsiaryna Laryionava, Katja Mehlis, Elena Bierwirth, Friederike Mumm, Wolfgang Hiddemann, Pia Heußner, Eva C. Winkler 
264 1 |c 15.06.18 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.02.2020 
520 |a Background: Many patients with advanced cancer receive chemotherapy close to death and are referred too late to palliative or hospice care, and therefore die under therapy or in intensive care units. Oncologists still have difficulties in involving patients appropriately in decisions about limiting tumor-specific or life-prolonging treatment. Objective: The aim of this Ethics Policy for Advanced Care Planning and Limiting Treatment Study is to develop an ethical guideline for end-of-life decisions and to evaluate the impact of this guideline on clinical practice regarding the following target goals: reduction of decisional conflicts, improvement of documentation transparency and traceability, reduction of distress of the caregiver team, and better knowledge and consideration of patients’ preferences. Methods: This is a protocol for a pre-post interventional study that analyzes the clinical practice on treatment limitation before and after the guideline implementation. An embedded researcher design with a mixed-method approach encompassing both qualitative and quantitative methods is used. The study consists of three stages: (1) the preinterventional phase, (2) the intervention (development and implementation of the guideline), and 3) the postinterventional phase (evaluation of the guideline’s impact on clinical practice). We evaluate the process of decision-making related to limiting treatment from different perspectives of oncologists, nurses, and patients; comparing them to each other will allow us to develop the guideline based on the interests of all parties. Results: The first preintervention data of the project have already been published, which detailed a qualitative study with oncologists and oncology nurses (n=29), where different approaches to initiation of end-of-life discussions were ethically weighted. A framework for oncologists was elaborated, and the study favored an anticipatory approach of preparing patients for forgoing therapy throughout the course of disease. Another preimplementational study of current decision-making practice (n=567 patients documented) demonstrated that decisions to limit treatment preceded the death of many cancer patients (62/76, 82% of deceased patients). However, such decisions were usually made in the last week of life, which was relatively late. Conclusions: The intervention will be evaluated with respect to the following endpoints: better knowledge and consideration of patients’ treatment wishes; reduction of decisional conflicts; improvement of documentation transparency and traceability; and reduction of the psychological and moral distress of a caregiver team. Registered Report Identifier: RR1-10.2196/9698 [JMIR Res Protoc 2018;7(6):e157] 
700 1 |a Mehlis, Katja  |e VerfasserIn  |0 (DE-588)1084144514  |0 (DE-627)848338154  |0 (DE-576)456212205  |4 aut 
700 1 |a Winkler, Eva C.  |d 1971-  |e VerfasserIn  |0 (DE-588)1055853065  |0 (DE-627)792734823  |0 (DE-576)411905384  |4 aut 
773 0 8 |i Enthalten in  |t JMIR Research Protocols  |d Toronto : JMIR Publications, 2012  |g 7(2018,6) Artikel-Nummer e157, 9 Seiten  |h Online-Ressource  |w (DE-627)749502304  |w (DE-600)2719222-2  |w (DE-576)383521181  |x 1929-0748  |7 nnas  |a Development and evaluation of an ethical guideline for decisions to limit life-prolonging treatment in advanced cancer protocol for a monocentric mixed-method interventional study 
773 1 8 |g volume:7  |g year:2018  |g number:6  |g extent:9  |a Development and evaluation of an ethical guideline for decisions to limit life-prolonging treatment in advanced cancer protocol for a monocentric mixed-method interventional study 
856 4 0 |u https://doi.org/10.2196/resprot.9698  |x Verlag  |x Resolving-System  |3 Volltext  |7 1 
856 4 0 |u https://www.researchprotocols.org/2018/6/e157/  |x Verlag  |7 1 
951 |a AR 
992 |a 20200225 
993 |a Article 
994 |a 2018 
998 |g 1055853065  |a Winkler, Eva C.  |m 1055853065:Winkler, Eva C.  |d 910000  |d 912900  |d 50000  |e 910000PW1055853065  |e 912900PW1055853065  |e 50000PW1055853065  |k 0/910000/  |k 1/910000/912900/  |k 0/50000/  |p 7  |y j 
998 |g 1084144514  |a Mehlis, Katja  |m 1084144514:Mehlis, Katja  |d 910000  |d 910100  |e 910000PM1084144514  |e 910100PM1084144514  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1038265509  |a Laryionava, Katsiaryna  |m 1038265509:Laryionava, Katsiaryna  |d 910000  |d 910100  |e 910000PL1038265509  |e 910100PL1038265509  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1690896442  |e 3598127340 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1690896442","origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"15.06.18"}],"note":["Gesehen am 25.02.2020"],"relHost":[{"pubHistory":["1.2012 -"],"disp":"Development and evaluation of an ethical guideline for decisions to limit life-prolonging treatment in advanced cancer protocol for a monocentric mixed-method interventional studyJMIR Research Protocols","id":{"issn":["1929-0748"],"zdb":["2719222-2"],"eki":["749502304"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"749502304","origin":[{"dateIssuedKey":"2012","publisher":"JMIR Publications","dateIssuedDisp":"2012-","publisherPlace":"Toronto"}],"language":["eng"],"part":{"extent":"9","year":"2018","text":"7(2018,6) Artikel-Nummer e157, 9 Seiten","volume":"7","issue":"6"},"title":[{"title_sort":"JMIR Research Protocols","title":"JMIR Research Protocols"}]}],"id":{"doi":["10.2196/resprot.9698"],"eki":["1690896442"]},"physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Katsiaryna Laryionava, Katja Mehlis, Elena Bierwirth, Friederike Mumm, Wolfgang Hiddemann, Pia Heußner, Eva C. Winkler"]},"person":[{"family":"Laryionava","display":"Laryionava, Katsiaryna","given":"Katsiaryna","role":"aut"},{"role":"aut","given":"Katja","display":"Mehlis, Katja","family":"Mehlis"},{"family":"Winkler","display":"Winkler, Eva C.","role":"aut","given":"Eva C."}],"language":["eng"],"title":[{"title_sort":"Development and evaluation of an ethical guideline for decisions to limit life-prolonging treatment in advanced cancer","subtitle":"protocol for a monocentric mixed-method interventional study","title":"Development and evaluation of an ethical guideline for decisions to limit life-prolonging treatment in advanced cancer"}]} 
SRT |a LARYIONAVADEVELOPMEN1506